Such ILPs could represent exciting exploitable scaffolds for future drug discovery in diabetes, as well as provide tools to allow for a better understanding of cell signaling pathways linked to insulin secretion and metabolism, which has potential biotechnology applications. This evidence concerns the gene INS and diabetes mellitus.